Clinical Trials Logo

Food Effect clinical trials

View clinical trials related to Food Effect.

Filter by:

NCT ID: NCT05690932 Completed - Food Effect Clinical Trials

A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers

Start date: February 24, 2022
Phase: Phase 1
Study type: Interventional

This is a single-dose, two-part, crossover formulation bridging and food effect study to assess the effect of formulation and food on the absorption and bioavailability of PBI-200 in normal, healthy volunteers.

NCT ID: NCT05217732 Completed - Pharmacokinetics Clinical Trials

Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers

Start date: December 1, 2021
Phase: Phase 1
Study type: Interventional

Randomized, double-blind and placebo-controled study to assess the safety, tolerability and pharmacokinetics of single ascending doses of ZX-7101A and its food effect in China healthy adult volunteers. The study is composed of 2 parts. Part 1 is to assess the safety, tolerability and pharmacokinetics of a single ascending doses of ZX-7101A tablet. Part 2 is to assess the food effect on ZX-7101A at a selected dose in a cross-over design.

NCT ID: NCT05187169 Completed - Food Effect Clinical Trials

Food Effect of VS-6766 in Healthy Adult Subjects

Start date: December 16, 2021
Phase: Phase 1
Study type: Interventional

An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766

NCT ID: NCT04501640 Completed - Food Effect Clinical Trials

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

Start date: September 21, 2020
Phase: Phase 4
Study type: Interventional

This study determined the effect of food on the pharmacokinetics (PK) of single oral doses of mirabegron in healthy Chinese male and female participants. This study also evaluated the safety and tolerability of single oral doses of mirabegron in healthy Chinese male and female participants.

NCT ID: NCT03885778 Completed - Food Effect Clinical Trials

A Food Effect Study of Besifovir in Healthy Subjects

Start date: January 13, 2019
Phase: Phase 4
Study type: Interventional

To investigate the PK characteristics and the effect of food on the PK in healthy volunteers who receive Besifovir dipivoxil in fed versus fasted condition

NCT ID: NCT03798197 Completed - Food-effect Clinical Trials

Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers

Start date: January 30, 2019
Phase: Phase 1
Study type: Interventional

Assessment of the effect of a high fat meal on the quantity in blood of a female sex hormone called estetrol (E4). The study also aims at determining how subject tolerate the study drug and how safe it is for them.

NCT ID: NCT03150498 Completed - Healthy Clinical Trials

A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001

Start date: May 3, 2017
Phase: Phase 1
Study type: Interventional

This is a single-centre, open-label study in healthy male and non-pregnant, non-lactating females. The study will consist of up to 2 parts; the decision to proceed to the optional second part will be made following review of Part 1 data. Part 1 is a single dose, two period crossover to assess food affect of oral BTD-001. Optional Part 2 is a non-randomised, single arm study multi dose design to evaluate PK profile of BTD-001

NCT ID: NCT02560363 Withdrawn - Pharmacokinetics Clinical Trials

A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects

Start date: November 2015
Phase: Phase 1
Study type: Interventional

This is an open-label, randomized, cross over single oral dose study to compare the pharmacokinetics of different formulations of AZD9977 in Part A and the influence of food in Part B in healthy male subjects

NCT ID: NCT02017236 Completed - Food Effect Clinical Trials

A Food Effect Phase I Study of the Volitinib in Healthy Subjects

HMPL-504
Start date: November 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 600 mg Volitinib and its two major metabolites in healthy subjects.

NCT ID: NCT01686217 Completed - Healthy Volunteers Clinical Trials

A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K

Start date: June 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the pharmacokinetics (PK) profiles of three different strengths of ASP015K extended release formulation and an immediate release formulation and to evaluate food effect on extended release strengths in healthy volunteers.